id: NEW:omega_3_pufa_supplementation_to_NEW:serum_triglycerides
name: Omega-3 PUFA Supplementation â†’ Serum Triglycerides
from_node:
  node_id: NEW:omega_3_pufa_supplementation
  node_name: Omega-3 PUFA Supplementation
to_node:
  node_id: NEW:serum_triglycerides
  node_name: Serum Triglycerides
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Omega-3 polyunsaturated fatty acids (EPA and DHA) are absorbed and incorporated
  into hepatic cell membranes and lipid metabolism pathways'
- 'Step 2: Omega-3 PUFAs activate peroxisome proliferator-activated receptors (PPARs)
  and suppress sterol regulatory element-binding protein-1c (SREBP-1c), reducing hepatic
  triglyceride synthesis'
- 'Step 3: Enhanced fatty acid beta-oxidation in the liver and reduced very low-density
  lipoprotein (VLDL) secretion leads to decreased circulating triglyceride levels'
- 'Step 4: Improved serum lipid profiles observed with significant reductions in triglycerides
  alongside improvements in LDL and total cholesterol'
evidence:
  quality_rating: A
  n_studies: 15
  primary_citation: 'Tarique Aziz et al. 2024. "Effectiveness of Omega-3 Polyunsaturated
    Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis."
    Cureus.'
  supporting_citations: []
description: Omega-3 PUFA supplementation significantly reduces serum triglyceride
  levels through multiple hepatic mechanisms including enhanced fatty acid oxidation,
  reduced lipogenesis via SREBP-1c suppression, and decreased VLDL secretion. A meta-analysis
  of 15 studies in NAFLD patients and animal models demonstrated significant improvements
  in serum lipid profiles with reductions in triglycerides, LDL, and total cholesterol.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: NAFLD presence
  direction: strengthens
  strength: moderate
  description: Effects studied specifically in NAFLD populations where baseline lipid
    dysregulation may enhance observable benefits
- name: Animal vs human models
  direction: strengthens
  strength: moderate
  description: Animal models showed significant reductions in triglycerides; human
    studies also demonstrated significant improvements in serum lipid profiles
